Johnson & Johnson : PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials

(marketscreener.com) Public-private collaboration to evaluate five antimicrobial agents across two combination regimens for treating both drug-susceptible and drug-resistant forms of TB with shorter treatment durations August 17, 2022 - The Project to Accelerate New Treatments for Tuberculosis collaboration announced today the...https://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-PAN-TB-Collaboration-to-Advance-Investigational-Tuberculosis-Drug-Regimens-to-Ph-41341471/?utm_medium=RSS&utm_content=20220817